Skip to Main Content

Paper Details

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.
Clin Pharmacol Ther
85
2014
Abacavir, HLA-B, pharmgkb
Author NameAffiliation
James M HoffmanDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Robert R FreimuthMayo Clinic
Teri E KleinStanford University
James K HicksDepartment of Pharmacy and Center for Personalized Healthcare, Cleveland Clinic
Mark R WilkinsonDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Mark R WilkinsonDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital
David W HaasVanderbilt University
David W HaasVanderbilt University
Deanna L KroetzUniversity of California san francisco
  • 1 - 9

Datasets

PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink